e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Paediatric airway diseases - pathophysiology and monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children
F. Saretta, M. Mauro, I. Benfatto, A. Orioles, A. Caglieri, M. Canciani (Udine, Parma, Italy)
Source:
Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Session:
Paediatric airway diseases - pathophysiology and monitoring
Session type:
E-Communication Session
Number:
1445
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Saretta, M. Mauro, I. Benfatto, A. Orioles, A. Caglieri, M. Canciani (Udine, Parma, Italy). Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children. Eur Respir J 2008; 32: Suppl. 52, 1445
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003
Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Increased exhaled nitric oxide in nonatopic asthma
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002
Reactive oxygen species generation and exhaled nitric oxide in atopic mild bronchial asthma in exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 617s
Year: 2007
Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma
Source: Eur Respir J 2016; 48: 242-244
Year: 2016
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003
Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Serum nitric oxide metabolists in bronchial asthma patients
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept